It is the first and only biologic developed to specifically neutralize IL-13, a key driver of atopic dermatitis signs and symptoms(1,2)
Learn more about how Adtralza® works and how to use it in treatment.By specifically targeting the IL-13 cytokine, Adtralza® inhibits the interaction with type II receptors and prevents IL-13-induced inflammatory responses in the skin(1,2).
Adtralza® selectively modulates the dysregulated immune system by(1):
Adtralza® has a straightforward dosing regimen, with 150 mg prefilled syringes(1).
Learn more about application and dosingAThis step by step video guide shows the patient how to self inject using the two syringes that come in the Adtralza® carton.
Watch the videoSee what Key opinion leaders have to say about their experiences with Adtralza®
Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image
Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image
Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image
Short description of the contents or subject of the video. You can upload a screen from the video as thumbnail image
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Alias accusantium pariatur quasi. Quaerat sunt earum nihil saepe, quam obcaecati inventore adipisci nam porro dolor itaque ipsum magni, molestiae nisi suscipit?